Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Bayer acquires British medical imaging AI developer Blackford

Published 01/18/2023, 02:34 AM
Updated 01/18/2023, 10:18 AM
© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo
BAYRY
-

By Ludwig Burger and Patricia Weiss

FRANKFURT (Reuters) - Bayer (OTC:BAYRY) agreed to acquire Blackford Analysis Ltd., a British developer of artificial intelligence (AI) systems that help diagnose disease from medical images, to boost the German company's radiology business.

Healthcare and agriculture company Bayer said in a statement on Wednesday that the deal was part of a strategy to expand in digital analysis of medical images, which are taken with the help of Bayer's contrast agents on computed tomography, X-ray, and magnetic resonance scanners.

The company declined to disclose the deal's financial terms.

In 2021, sales at Bayer's radiology business with its contrast agents, injection systems and software accounted for 1.8 billion euros ($1.95 billion) of 44 billion euros in group sales.

During the third quarter of last year the radiology business saw sales increase 7% on growing demand for scans of cardiovascular disease and tumours.

© Reuters. FILE PHOTO: Logo of Bayer AG is pictured at the annual results news conference of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay/File Photo

Founded in 2010, Blackford's financial backers include Archangel Investors, TRI Cap, Scottish Enterprise and Old College Capital.

($1 = 0.9239 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.